1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Emphysema or COPD: new trials by email Literature Review of Emphysema or COPD trials Research Report on Emphysema or COPD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure CD3/CD19 negative hematopoietic stem cells, Rituximab, Alemtuzumab - Idiopathic Pulmonary Fibrosis, Emphysema or COPD | Phase 1 / Phase 2 | Recruiting | Paul Szabolcs | 8 | 2018-04-19 | 2026-01-13 |
Emphysema (1) · Idiopathic Pulmonary Fibrosis (1) · Pulmonary Disease, Chronic Obstructive (1) · Pulmonary Fibrosis (1)
Chronic Disease (1) · Disease Attributes (1) · Fibrosis (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Alemtuzumab (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Hydroxyurea (1) · Rituximab (1) · Thiotepa (1) · fludarabine (1) · fludarabine phosphate (1)
Paul Szabolcs (1)
United States (1)